Switching to the oral small molecule glucagon-like peptide-1 (GLP-1) orforglipron after taking injectable GLP-1s helped patients maintain most of their weight loss, a clinical trial involving Weill Cornell Medicine has found.
While recreational cannabis laws have significantly reduced arrests for cannabis possession and sales, racial disparities in arrests still exist, according to a new study from Weill Cornell Medicine, Instituto Tecnológico Autónomo de México and the University of Texas at Austin.
All life forms need to continuously adapt to temperature changes to survive. Now, Weill Cornell Medicine investigators studying a bacterial protein have identified a new mechanism of sensing cold temperatures.
Ultra-personalized AI for assisted communication risks muting aspects of the user’s identity and can breach privacy, according to a study from a Cornell Tech doctoral student who trained the technology on himself.
As the 2025–26 academic year comes to a close, Cornell Tech will host a series of events throughout May showcasing student achievement, entrepreneurship, design, and the future of emerging technologies.
Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body’s defense systems, according to a study led by investigators at Weill Cornell Medicine.
